ADENOCARD
What it isEndogenous purine nucleoside acting at A1 to A3 receptors; IV bolus for supraventricular tachycardia.
Why this oneA half-life of seconds means a transient AV block that terminates re-entrant SVT and then vanishes.
What limits itGive it fast into a large vein with a flush, and warn the patient about the brief sense of doom. Dipyridamole potentiates it; theophylline blocks it.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Paroxysmal supraventricular tachycardia (conversion) | Adult | 6 mg rapid IV bolus | If no response in 1–2 min, 12 mg rapid IV bolus; may repeat 12 mg once | 12 mg per dose |
| Paroxysmal supraventricular tachycardia (conversion) | Pediatric <50 kg | 0.05–0.1 mg/kg rapid IV bolus | Increase by 0.05–0.1 mg/kg each repeat until sinus rhythm | 0.3 mg/kg single dose |
| Paroxysmal supraventricular tachycardia (conversion) | Pediatric ≥50 kg | Adult dose (6 mg) | 12 mg if needed | 12 mg per dose |
Renal Undefined
Hepatic Undefined
Doses greater than 12 mg are not recommended for adult or pediatric patients.
Pregnancy No animal or human studies; as a naturally occurring substance fetal effects not anticipated, but use during pregnancy only if clearly needed (former Category C).
Lactation Undefined
NO BOXED WARNINGS
Principal riskA brief but severe sense of doom; theophylline blocks it

Open Adenosine in the interactive console ↗
